Charles River has proudly partnered with the EBD Group to provide the scientific program for this year’s BioPharm America™ Conference. This exciting two-day program aims to bridge the gap between drug discovery and clinical application. Driven by the bedside-to-bench experience, industry leaders will come together to discuss innovations and breakthroughs in translational tools and methods in drug discovery research and development. Attendees will gain insight into how clinical data can be used to successfully develop the next generation of animal models, tools and technologies that lead to the development of effective therapies.

Elazer Edelman, Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at IMES, is featured as a keynote speaker on the topic “Historical Perspective on Reverse Translational Medicine.”

The conference will be held on September 26 & 27, 2017 at the Sheraton Copley Place in Boston, MA.

Register and learn more here: http://breakthroughs.criver.com